Simultaneous Uptake of I-131 and F-18 FDG by a Renal Metastasis of Thyroid Papillary Cancer

被引：6
|
作者：
Oh, Jong-Ryool [1 ]
Lim, Jae-Hoon [2 ]
Jeong, Shin-Young [1 ]
Heo, Suk-Hee [2 ]
Chong, Ari [1 ]
Min, Jung-Joon [1 ,3 ]
机构：
[1] Chonnam Natl Univ, Hwasun Hosp, Dept Nucl Med, Hwasun 519809, Jeonnam, South Korea
[2] Chonnam Natl Univ, Hwasun Hosp, Dept Radiol, Hwasun 519809, Jeonnam, South Korea
[3] Chonnam Natl Univ, Brain Korea Project 21, Ctr Biomed Human Resources, Kwangju, South Korea
来源：
CLINICAL NUCLEAR MEDICINE | 2011年 / 36卷 / 09期
关键词：
renal metastasis; thyroid papillary cancer; SPECT/CT; iodine scan; KIDNEY;
D O I：
10.1097/RLU.0b013e318219b148
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Renal metastasis of thyroid papillary cancer is rare and only a few cases have been reported. Most metastases of well-differentiated thyroid cancer alternatively accumulate either I-131 or F-18 fluorodeoxyglucose (FDG), according to tumor differentiation, and only a few metastases exhibit simultaneous I-131 and F-18 FDG uptake. This study shows the simultaneous I-131 and F-18 FDG uptake of metastatic renal mass in a patient with a 10-year history of thyroid papillary cancer. In our knowledge, this is the first report of thyroid cancer with renal metastasis as imaged by both I-131 SPECT/CT and F-18 FDG PET/CT.
引用
收藏
页码：798 / 799
页数：2
相关论文
共 50 条
  • [31] Strengths and weaknesses of F-18 FDG-PET in the follow-up of high risk thyroid cancer patients with negative diagnostic I-131 scans.
    Lawson, MA
    Seabold, JE
    Kirchner, PT
    Bishop, HA
    Gupta, NC
    Chen, K
    Bandy, D
    Frost, J
    Goodwin, S
    Mullen, L
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 19P - 19P
  • [32] F-18 FDG uptake in borderline intraductal papillary neoplasms of the bile duct
    Aisheng Dong
    Hui Dong
    Ling Zhang
    Changjing Zuo
    Annals of Nuclear Medicine, 2012, 26 : 594 - 598
  • [33] F-18 FDG uptake in borderline intraductal papillary neoplasms of the bile duct
    Dong, Aisheng
    Dong, Hui
    Zhang, Ling
    Zuo, Changjing
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (07) : 594 - 598
  • [34] I-131 TREATMENT OF THYROID PAPILLARY CARCINOMA IN A PATIENT WITH RENAL-FAILURE
    MORRISH, DW
    FILIPOW, LJ
    MCEWAN, AJ
    SCHMIDT, R
    MURLAND, KR
    VONWESTARP, C
    BETCHER, KB
    CANCER, 1990, 66 (12) : 2509 - 2513
  • [35] F-18 FDG PET/CT in the management of thyroid cancer
    Iagaru, Andrei
    Kalinyak, Judith E.
    McDougall, I. Ross
    CLINICAL NUCLEAR MEDICINE, 2007, 32 (09) : 690 - 695
  • [36] Percent I-131 uptake and post-therapy I-131 scans: Their role in the management of thyroid cancer
    Reynolds, JC
    THYROID, 1997, 7 (02) : 281 - 284
  • [37] MEASUREMENT OF I-131 THYROID UPTAKE IN NIGERIANS
    FREGENE, AO
    DARAMOLA, GF
    NIGERIAN MEDICAL JOURNAL, 1974, 4 (03): : 152 - 154
  • [38] THE INFLUENCE OF HYPOTHERMIA ON THE UPTAKE OF I-131 BY THE THYROID
    VERZAR, F
    VIDOVIC, V
    HAJDUKOVIC, S
    JOURNAL OF ENDOCRINOLOGY, 1953, 10 (01) : 46 - 53
  • [39] Pre-Therapy Hyperfunctioning Follicular Thyroid Carcinoma Evaluation With I-131 Whole-Body Scan and With F-18 FDG PET/CT
    Orsolon, Piergiuseppe
    Giachetti, Marcello
    Lupi, Andrea
    Salgarello, Matteo
    Malfatti, Veronica
    Zanco, Pierluigi
    CLINICAL NUCLEAR MEDICINE, 2008, 33 (12) : 882 - 886
  • [40] Early Prediction of Response to Radioimmunotherapy with I-131 Rituximab in Lymphoma Using Sequential F-18 FDG PET/CT
    Byun, Byung Hyun
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
12345